Esperion to Participate in Upcoming H.C. Wainwright Global Investment Conference
May 17 2022 - 8:00AM
Esperion (NASDAQ: ESPR), today announced that President and Chief
Executive Officer, Sheldon Koenig, will participate in a fireside
chat at the upcoming H.C. Wainwright Global Investment Conference
on Tuesday, May 24th, 2022.
Event: |
H.C. Wainwright Global Investment Conference |
Date: |
Tuesday, May 24th, 2022 |
Format: |
Presentation and 1:1 Meetings |
Time: |
7:00 am Eastern Standard Time |
Webcast: |
Link |
A live audio webcast can be accessed on the investor and media
section of the Esperion website at
https://www.esperion.com/investor-relations/events. Access to the
webcast replay will be available approximately two hours after
completion of the call and will be archived on the Company's
website for approximately 90 days.
Esperion Therapeutics
Esperion works hard to make our medicines easy to get, easy to
take and easy to have. We discover, develop and commercialize
innovative medicines and combinations to lower cholesterol,
especially for patients whose needs aren’t being met by the status
quo. Our entrepreneurial team of industry leaders is inclusive,
passionate and resourceful. We are singularly focused on managing
cholesterol so you can improve your health easily. Esperion is the
leader in the development of convenient oral, once-daily non-statin
LDL-cholesterol lowering drugs for patients with high levels of bad
cholesterol. For more information, please visit www.esperion.com
and follow us on Twitter at www.twitter.com/EsperionInc.
Contact:Corporate Communicationscorporateteam@esperion.com
Esperion Therapeutics (NASDAQ:ESPR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Esperion Therapeutics (NASDAQ:ESPR)
Historical Stock Chart
From Apr 2023 to Apr 2024